Fas and Fas ligand in gut and liver

M J Pinkoski1, T Brunner, D R Green

  • 1Division of Cellular Immunology, La Jolla Institute for Allergy and Immunology, San Diego, California 92121, USA.

Insights

The Fas/Fas ligand (FasL) system, a key apoptosis pathway, is crucial in liver and gastrointestinal diseases. This review explores Fas/FasL

Area of Science:

  • Cell Biology
  • Immunology
  • Gastroenterology

Background:

  • Apoptosis, or programmed cell death, is vital in development and disease pathogenesis.
  • Death receptors and their ligands mediate apoptosis via cell surface interactions.
  • The Fas/Fas ligand (FasL) system is a well-studied pathway involving FasL signaling through the Fas receptor.

Purpose of the Study:

  • To review the Fas/FasL system.
  • To examine the evidence linking Fas/FasL to liver and gastrointestinal diseases.

Main Methods:

  • Literature review of studies on the Fas/FasL system.
  • Analysis of evidence implicating Fas/FasL in disease pathogenesis.

Main Results:

  • The Fas/FasL system is a principal mechanism of apoptosis.
  • Fas/FasL is expressed on numerous liver and gastrointestinal cells.
  • Growing evidence links Fas/FasL to diseases like inflammatory bowel disease, graft vs. host disease, and hepatitis.

Conclusions:

  • The Fas/FasL system plays a significant role in the pathogenesis of various liver and gastrointestinal diseases.
  • Understanding the Fas/FasL pathway is critical for disease research and potential therapeutic strategies.